The pharmaceutical industry does not make a move without knowing what is coming down the pike, or without global projections years into the future. This latest maneuver is standard fare.
How lucky we are to be alive when, while enduring catastrophic events, the possibility of real-time help is literally at our fingertips.
When ideology not medical reasoning guides infant feeding policy, nobody wins.
First Lady Melania Trump underwent a "successful" embolization procedure for what was described as a "benign kidney condition." But if the condition is benign, why intervene?
Dr. Oz is a fraud who ought to be fired from Columbia University and have his medical license revoked. Instead, he's headed to the White House.
ACSH Director of Medicine Dr. Jamie Wells traveled to Washington, DC to spend the afternoon with White House Physician to the President Rear Adm. Ronny Jackson.
With President Trump's annual physical looming, what matters most? And specifically, what would it take to make a president unfit to serve?
The actor and musician knows how to convey a message that effects medical change, helped in part by his visit top be with sick kids at Children's Hospital Los Angeles. Now, let's see if Hollywood follows suit.
The president's budget proposal for 2018 should raise some serious concerns. Cutting science funding, particularly that of the National Institutes of Health, is not aligned with his goal to "Make America Great Again."
We recently discussed the impact of President Trump's address before Congress (and the world) on the rare Pompe disease. Now, we dive into the topic of why these types of “Orphan Diseases” are so important to understand and be aware of, as to help promote and encourage therapeutic and potentially-curative research.
During his address to Congress this week President Trump shone a spotlight on Megan Crowley, a 20-year-old Notre Dame sophomore with Pompe Disease, which is caused by mutations in the GAA gene.
A grassroots science movement has amassed a gigantic following on social media, which in turn has resulted in substantial mainstream media coverage. The site, still in development, states that "anyone who values empirical science" can participate. That's good. Unfortunately, other statements are sending mixed messages.